XTL Biopharmaceuticals Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Shlomo Shalev
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 4.3yrs |
CEO ownership | 0.2% |
Management average tenure | no data |
Board average tenure | 9.5yrs |
Recent management updates
Recent updates
CEO
Shlomo Shalev (62 yo)
4.3yrs
Tenure
Mr. Shlomo Spokone Shalev serves as Chief Executive Officer at XTL Biopharmaceuticals Ltd. since May 19, 2020. He has been the Chairman of the board of directors at G.F.C Green Fields Capital Ltd.since 1...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 9.8yrs | no data | 0.25% $ 76.4k | |
Non-Executive Chairman of the Board | 9.8yrs | no data | 0.028% $ 8.6k | |
Member of Clinical Advisory Board | no data | no data | no data | |
Member of Clinical Advisory Board | no data | no data | no data | |
Non-Executive Director | 9.8yrs | no data | 0% $ 0 | |
Independent Non-Executive Director | 9.8yrs | no data | 0% $ 0 | |
Member of Clinical Advisory Board | no data | no data | no data | |
Independent Non-Executive & External Director | 9.5yrs | no data | 0% $ 0 | |
Member of Clinical Advisory Board | 9yrs | no data | no data | |
Member of Clinical Advisory Board | 7.6yrs | no data | no data | |
Member of Clinical Advisory Board | 7.6yrs | no data | no data | |
Non-Executive Director | 7.4yrs | no data | no data |
9.5yrs
Average Tenure
58yo
Average Age
Experienced Board: XTLB's board of directors are considered experienced (9.5 years average tenure).